Joseph Farmer compensation by year
Zenas BioPharma Summary Compensation Table · all 2 fiscal years held| Component | FY2024 | FY2025 |
|---|---|---|
| Salary | $500,000 | $520,000 |
| Bonus | $0 | $0 |
| Stock awards | $0 | $0 |
| Option awards | $5,247,000 | $1,649,025 |
| Non-equity incentive | $255,600 | $336,700 |
| Pension and deferred compensation | $0 | $0 |
| All other | $1,854 | $20,800 |
| Total | $6,004,454 | $2,526,525 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Zenas BioPharma, Inc. DEF 14A filed March 16, 2026, accession 0001104659-26-028062, and prior-year filings.
How this page was built: the Zenas BioPharma, Inc. filed document, accession 0001104659-26-028062. Every figure is read from that document and cited to the page and table it appears in. Filed March 16, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 40,308 | — | $9.30 |
| Option | 30,772 | — | $9.30 |
| Option | 189,605 | — | $9.99 |
| Option | 141,625 | — | $17.00 |
| Option | 175,000 | — | $11.94 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Zenas BioPharma, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Zenas BioPharma’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Leon Moulder | Founder, Chief Executive Officer and Chairman | $4,661,000 |
| Lisa von Moltke | Head of Research and Development and Chief Medical Officer | $3,499,447 |
| Joseph Farmer · this page | President and Chief Operating Officer | $2,526,525 |
Joseph Farmer's compensation dossier, Zenas BioPharma
You have read Joseph Farmer's totals and holdings. The dossier adds each equity grant Zenas BioPharma disclosed for Joseph Farmer and Zenas BioPharma's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full Zenas BioPharma compensation record
free company briefThis page is one person within Zenas BioPharma's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Zenas BioPharma's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Zenas BioPharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.